Simplify Medical raised $21 million in series B funding to support two U.S. pivotal trials of its nonmetal cervical artificial disc.
BGI Genomics has completed its IPO, giving it cash at a time when it is trying to establish itself as a major player in biomedical testing.
Allurion Technologies has raised $27 million in series C funding for its swallowable, procedureless, weight-loss balloon.
Dune Medical, which markets a tool that spots residual breast cancer cells following a lumpectomy, has raised $12.3 million.
Axonics Modulation Technologies raised $20.5 million in the second closing of its series C financing.
Creavo Medical Technologies has raised $17 million to develop its heart attack test.
Digital diabetes management player Glooko raised $35 million to further develop its technology and expand in a number of markets.
SerImmune, whose technology maps the human antibody repertoire, rounded up $8 million from Merck, Illumina Ventures and unnamed investors.
Mindstrong Health raised $14 million in its Series A, which it will use to build out its technology and clinical operations teams.
Myomo completed its initial public offering via an SEC rule that makes it easier for smaller companies to access capital.